Alkemy Capital Investments (ALK) Competitors GBX 123 -3.50 (-2.77%) As of 03:38 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock ALK vs. PXS, CLCO, ICON, PAA, GEL, MMP, AAL, CCL, SAVE, and GNKShould you be buying Alkemy Capital Investments stock or one of its competitors? The main competitors of Alkemy Capital Investments include Provexis (PXS), CloudCoCo Group (CLCO), Iconic Labs (ICON), 22532 (PAA.L) (PAA), Greka Engineering & Technology (GEL), Marwyn Management Partners (MMP), Anglo American (AAL), Carnival Co. & (CCL), Savannah Energy (SAVE), and Greene King (GNK). These companies are all part of the "transportation" industry. Alkemy Capital Investments vs. Provexis CloudCoCo Group Iconic Labs 22532 (PAA.L) Greka Engineering & Technology Marwyn Management Partners Anglo American Carnival Co. & Savannah Energy Greene King Provexis (LON:PXS) and Alkemy Capital Investments (LON:ALK) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, community ranking, risk, valuation, earnings and dividends. Do insiders and institutionals have more ownership in PXS or ALK? 7.9% of Provexis shares are owned by institutional investors. Comparatively, 1.5% of Alkemy Capital Investments shares are owned by institutional investors. 21.6% of Provexis shares are owned by insiders. Comparatively, 43.7% of Alkemy Capital Investments shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, PXS or ALK? Provexis has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500. Comparatively, Alkemy Capital Investments has a beta of 1.78, indicating that its share price is 78% more volatile than the S&P 500. Does the MarketBeat Community favor PXS or ALK? Alkemy Capital Investments received 92 more outperform votes than Provexis when rated by MarketBeat users. Likewise, 76.88% of users gave Alkemy Capital Investments an outperform vote while only 64.21% of users gave Provexis an outperform vote. CompanyUnderperformOutperformProvexisOutperform Votes6164.21% Underperform Votes3435.79% Alkemy Capital InvestmentsOutperform Votes15376.88% Underperform Votes4623.12% Does the media prefer PXS or ALK? In the previous week, Provexis' average media sentiment score of 0.00 equaled Alkemy Capital Investments'average media sentiment score. Company Overall Sentiment Provexis Neutral Alkemy Capital Investments Neutral Which has higher earnings & valuation, PXS or ALK? Provexis has higher revenue and earnings than Alkemy Capital Investments. Provexis is trading at a lower price-to-earnings ratio than Alkemy Capital Investments, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProvexis£846.98K12.19-£619.15K-£0.03-16.68Alkemy Capital InvestmentsN/AN/A-£1.29M-£14.59-8.64 Is PXS or ALK more profitable? Alkemy Capital Investments has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Alkemy Capital Investments' return on equity of 181.08% beat Provexis' return on equity.Company Net Margins Return on Equity Return on Assets Provexis-73.10% -68.68% -56.14% Alkemy Capital Investments N/A 181.08%-258.00% SummaryAlkemy Capital Investments beats Provexis on 7 of the 12 factors compared between the two stocks. Remove Ads Get Alkemy Capital Investments News Delivered to You Automatically Sign up to receive the latest news and ratings for ALK and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALK vs. The Competition Export to ExcelMetricAlkemy Capital InvestmentsShell Companies IndustryFinancial SectorLON ExchangeMarket Cap£11.11M£31.41M£4.22B£2.57BDividend YieldN/A4.81%4.19%4.95%P/E Ratio-8.640.5416.15140.12Price / SalesN/A457.071,684.97262,597.20Price / Cash1,550.00196.4449.0827.90Price / Book-10.2092.083.344.54Net Income-£1.29M-£141.08M£1.28B£5.76B7 Day Performance-5.44%0.36%-1.00%0.34%1 Month Performance1.00%0.11%5.96%5.74%1 Year Performance52.73%3.36%9.77%107.79% Alkemy Capital Investments Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALKAlkemy Capital InvestmentsN/AGBX 123-2.8%N/A+52.7%£10.84MN/A-8.4325,500PXSProvexisN/AGBX 0.50+2.0%N/A-29.6%£11.73M£846,984.38-18.964Gap DownCLCOCloudCoCo GroupN/AGBX 0.16flatN/A-86.9%£1.12M£27.84M-0.53125Earnings ReportHigh Trading VolumeICONIconic LabsN/AN/AN/AN/A£586,000.00£600,855.00-15.003Earnings ReportNegative NewsGap UpHigh Trading VolumePAA22532 (PAA.L)N/AN/AN/AN/A£0.00N/A0.004,100Gap UpHigh Trading VolumeGELGreka Engineering & TechnologyN/AN/AN/AN/A£0.00N/A0.002,110MMPMarwyn Management PartnersN/AN/AN/AN/A£0.00N/A0.001,660AALAnglo American2.0847 of 5 starsGBX 2,380-0.6%GBX 2,698.33+13.4%+9.8%£36.19B£36.94B-21.92129,700Analyst ForecastGap DownHigh Trading VolumeCCLCarnival Co. &N/AGBX 1,470-0.1%N/A+14.9%£26.56B£32.78B13.3240,000SAVESavannah EnergyN/AGBX 7.70+0.7%N/A-69.4%£10.10B£18.46B-5.0011,100GNKGreene KingN/AN/AN/AN/A£2.63B£2.22B21.941,010High Trading Volume Remove Ads Related Companies and Tools Related Companies PXS Alternatives CLCO Alternatives ICON Alternatives PAA Alternatives GEL Alternatives MMP Alternatives AAL Alternatives CCL Alternatives SAVE Alternatives GNK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:ALK) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredOil Surge Predicted... But Are You Ready?Do you own oil and gas stocks? Or are you thinking about buying some? But it's NOT oil stocks, futures, or ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alkemy Capital Investments Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Alkemy Capital Investments With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALK Stock Free ALK Stock Alerts